{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T17:29:11Z","timestamp":1743010151209,"version":"3.40.3"},"publisher-location":"New York, NY","reference-count":31,"publisher":"Springer US","isbn-type":[{"type":"print","value":"9781071642160"},{"type":"electronic","value":"9781071642177"}],"license":[{"start":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T00:00:00Z","timestamp":1732147200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T00:00:00Z","timestamp":1732147200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025]]},"DOI":"10.1007\/978-1-0716-4217-7_7","type":"book-chapter","created":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T15:05:19Z","timestamp":1732115119000},"page":"69-81","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cardiomyocyte-Specific FoxO1 Knockout Mice as Tools to Assess Cardiac Hypertrophy and Key Experimental Considerations Using Cre-loxP"],"prefix":"10.1007","author":[{"given":"Kate L.","family":"Weeks","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie R.","family":"McMullen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,11,21]]},"reference":[{"issue":"14","key":"7_CR1","doi-asserted-by":"publisher","first-page":"5166","DOI":"10.1073\/pnas.85.14.5166","volume":"85","author":"B Sauer","year":"1988","unstructured":"Sauer B, Henderson N (1988) Site-specific DNA recombination in mammalian cells by the Cre recombinase of bacteriophage P1. Proc Natl Acad Sci USA 85(14):5166\u20135170. https:\/\/doi.org\/10.1073\/pnas.85.14.5166","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"7_CR2","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/0092-8674(81)90180-x","volume":"25","author":"S Austin","year":"1981","unstructured":"Austin S, Ziese M, Sternberg N (1981) A novel role for site-specific recombination in maintenance of bacterial replicons. Cell 25(3):729\u2013736. https:\/\/doi.org\/10.1016\/0092-8674(81)90180-x","journal-title":"Cell"},{"issue":"1","key":"7_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/cpmo.22","volume":"7","author":"MA McLellan","year":"2017","unstructured":"McLellan MA, Rosenthal NA, Pinto AR (2017) Cre-loxP-mediated recombination: general principles and experimental considerations. Curr Protoc Mouse Biol 7(1):1\u201312. https:\/\/doi.org\/10.1002\/cpmo.22","journal-title":"Curr Protoc Mouse Biol"},{"key":"7_CR4","doi-asserted-by":"publisher","unstructured":"Weeks KL, Tham YK, Yildiz SG, Alexander Y, Donner DG, Kiriazis H et al (2021) FoxO1 is required for physiological cardiac hypertrophy induced by exercise but not by constitutively active PI3K. Am J Physiol Heart Circ Physiol. https:\/\/doi.org\/10.1152\/ajpheart.00838.2020","DOI":"10.1152\/ajpheart.00838.2020"},{"issue":"4","key":"7_CR5","doi-asserted-by":"publisher","first-page":"H840","DOI":"10.1152\/ajpheart.00632.2019","volume":"318","author":"D Prakoso","year":"2020","unstructured":"Prakoso D, De Blasio MJ, Tate M, Kiriazis H, Donner DG, Qian H et al (2020) Gene therapy targeting cardiac phosphoinositide 3-kinase (p110alpha) attenuates cardiac remodeling in type 2 diabetes. Am J Physiol Heart Circ Physiol 318(4):H840\u2013HH52. https:\/\/doi.org\/10.1152\/ajpheart.00632.2019","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"7_CR6","doi-asserted-by":"publisher","unstructured":"Bernardo BC, Weeks KL, Pretorius L, McMullen JR. Molecular distinction between physiological and pathological cardiac hypertrophy: experimental findings and therapeutic strategies. Pharmacol Ther 2010;128(1):191\u2013227. S0163-7258(10)00079-3 [pii] https:\/\/doi.org\/10.1016\/j.pharmthera.2010.04.005","DOI":"10.1016\/j.pharmthera.2010.04.005"},{"issue":"1","key":"7_CR7","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1152\/physrev.00043.2016","volume":"98","author":"BC Bernardo","year":"2018","unstructured":"Bernardo BC, Ooi JYY, Weeks KL, Patterson NL, McMullen JR (2018) Understanding key mechanisms of exercise-induced cardiac protection to mitigate disease: current knowledge and emerging concepts. Physiol Rev 98(1):419\u2013475. https:\/\/doi.org\/10.1152\/physrev.00043.2016","journal-title":"Physiol Rev"},{"issue":"10","key":"7_CR8","doi-asserted-by":"publisher","first-page":"2757","DOI":"10.1016\/j.celrep.2018.08.017","volume":"24","author":"YK Tham","year":"2018","unstructured":"Tham YK, Bernardo BC, Huynh K, Ooi JYY, Gao XM, Kiriazis H et al (2018) Lipidomic profiles of the heart and circulation in response to exercise versus cardiac pathology: a resource of potential biomarkers and drug targets. Cell Rep 24(10):2757\u20132772. https:\/\/doi.org\/10.1016\/j.celrep.2018.08.017","journal-title":"Cell Rep"},{"key":"7_CR9","doi-asserted-by":"publisher","first-page":"1111819","DOI":"10.3389\/fimmu.2023.1111819","volume":"14","author":"CA Isidoro","year":"2023","unstructured":"Isidoro CA, Deniset JF (2023) The role of macrophage subsets in and around the heart in modulating cardiac homeostasis and pathophysiology. Front Immunol 14:1111819. https:\/\/doi.org\/10.3389\/fimmu.2023.1111819","journal-title":"Front Immunol"},{"key":"7_CR10","doi-asserted-by":"publisher","first-page":"416","DOI":"10.3389\/fphys.2020.00416","volume":"11","author":"X Fu","year":"2020","unstructured":"Fu X, Liu Q, Li C, Li Y, Wang L (2020) Cardiac fibrosis and cardiac fibroblast lineage-tracing: recent advances. Front Physiol 11:416. https:\/\/doi.org\/10.3389\/fphys.2020.00416","journal-title":"Front Physiol"},{"issue":"4","key":"7_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.xpro.2021.100866","volume":"2","author":"GE Farrugia","year":"2021","unstructured":"Farrugia GE, McLellan MA, Weeks KL, Matsumoto A, Cohen CD, Krstevski C et al (2021) A protocol for rapid and parallel isolation of myocytes and non-myocytes from multiple mouse hearts. STAR Protoc 2(4):100866. https:\/\/doi.org\/10.1016\/j.xpro.2021.100866","journal-title":"STAR Protoc"},{"key":"7_CR12","doi-asserted-by":"publisher","unstructured":"Schmitt-Ney M (2020) The FOXO\u2019s advantages of being a family: considerations on function and evolution. Cells 9(3). https:\/\/doi.org\/10.3390\/cells9030787","DOI":"10.3390\/cells9030787"},{"issue":"2","key":"7_CR13","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.bbadis.2016.11.023","volume":"1863","author":"Z Xin","year":"2017","unstructured":"Xin Z, Ma Z, Jiang S, Wang D, Fan C, Di S et al (2017) FOXOs in the impaired heart: new therapeutic targets for cardiac diseases. Biochim Biophys Acta Mol basis Dis 1863(2):486\u2013498. https:\/\/doi.org\/10.1016\/j.bbadis.2016.11.023","journal-title":"Biochim Biophys Acta Mol basis Dis"},{"key":"7_CR14","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.arr.2017.11.002","volume":"41","author":"Z Xin","year":"2018","unstructured":"Xin Z, Ma Z, Hu W, Jiang S, Yang Z, Li T et al (2018) FOXO1\/3: potential suppressors of fibrosis. Ageing Res Rev 41:42\u201352. https:\/\/doi.org\/10.1016\/j.arr.2017.11.002","journal-title":"Ageing Res Rev"},{"issue":"1","key":"7_CR15","doi-asserted-by":"publisher","first-page":"H58","DOI":"10.1152\/ajpheart.00157.2018","volume":"315","author":"DG Donner","year":"2018","unstructured":"Donner DG, Kiriazis H, Du XJ, Marwick TH, McMullen JR (2018) Improving the quality of preclinical research echocardiography: observations, training, and guidelines for measurement. Am J Physiol Heart Circ Physiol 315(1):H58\u2013h70. https:\/\/doi.org\/10.1152\/ajpheart.00157.2018","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"3","key":"7_CR16","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/s44161-023-00223-z","volume":"2","author":"YK Tham","year":"2023","unstructured":"Tham YK, Bernardo BC, Claridge B, Yildiz GS, Woon LM, Bond S et al (2023) Estrogen receptor alpha deficiency in cardiomyocytes reprograms the heart-derived extracellular vesicle proteome and induces obesity in female mice. Nat. Cardiovasc. Res 2(3):268\u2013289. https:\/\/doi.org\/10.1038\/s44161-023-00223-z","journal-title":"Nat. Cardiovasc. Res"},{"key":"7_CR17","doi-asserted-by":"publisher","unstructured":"Lin RC, Weeks KL, Gao XM, Williams RB, Bernardo BC, Kiriazis H, et al. PI3K(p110 alpha) protects against myocardial infarction-induced heart failure: identification of PI3K-regulated miRNA and mRNA. Arterioscler Thromb Vasc Biol 2010;30(4):724\u2013732. 30\/4\/724 [pii] https:\/\/doi.org\/10.1161\/ATVBAHA.109.201988","DOI":"10.1161\/ATVBAHA.109.201988"},{"key":"7_CR18","doi-asserted-by":"publisher","unstructured":"McMullen JR, Amirahmadi F, Woodcock EA, Schinke-Braun M, Bouwman RD, Hewitt KA, et al. Protective effects of exercise and phosphoinositide 3-kinase(p110alpha) signaling in dilated and hypertrophic cardiomyopathy. Proc Natl Acad Sci USA 2007;104(2):612\u2013617. 0606663104 [pii] https:\/\/doi.org\/10.1073\/pnas.0606663104","DOI":"10.1073\/pnas.0606663104"},{"key":"7_CR19","doi-asserted-by":"publisher","unstructured":"Pretorius L, Du XJ, Woodcock EA, Kiriazis H, Lin RC, Marasco S, et al. Reduced phosphoinositide 3-kinase (p110alpha) activation increases the susceptibility to atrial fibrillation. Am J Pathol 2009;175(3):998\u20131009. ajpath.2009.090126 [pii]. https:\/\/doi.org\/10.2353\/ajpath.2009.090126","DOI":"10.2353\/ajpath.2009.090126"},{"issue":"3","key":"7_CR20","doi-asserted-by":"publisher","first-page":"H627","DOI":"10.1152\/ajpheart.00327.2019","volume":"317","author":"KL Weeks","year":"2019","unstructured":"Weeks KL, Henstridge DC, Salim A, Shaw JE, Marwick TH, McMullen JR (2019) CORP: practical tools for improving experimental design and reporting of laboratory studies of cardiovascular physiology and metabolism. Am J Phys Heart Circ Phys 317(3):H627\u2013HH39. https:\/\/doi.org\/10.1152\/ajpheart.00327.2019","journal-title":"Am J Phys Heart Circ Phys"},{"issue":"12","key":"7_CR21","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1172\/JCI7605","volume":"104","author":"ED Abel","year":"1999","unstructured":"Abel ED, Kaulbach HC, Tian R, Hopkins JC, Duffy J, Doetschman T et al (1999) Cardiac hypertrophy with preserved contractile function after selective deletion of GLUT4 from the heart. J Clin Invest 104(12):1703\u20131714","journal-title":"J Clin Invest"},{"issue":"5","key":"7_CR22","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.cardfail.2006.03.002","volume":"12","author":"A Buerger","year":"2006","unstructured":"Buerger A, Rozhitskaya O, Sherwood MC, Dorfman AL, Bisping E, Abel ED et al (2006) Dilated cardiomyopathy resulting from high-level myocardial expression of Cre-recombinase. J Card Fail 12(5):392\u2013398","journal-title":"J Card Fail"},{"key":"7_CR23","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.yjmcc.2015.06.019","volume":"86","author":"EK Pugach","year":"2015","unstructured":"Pugach EK, Richmond PA, Azofeifa JG, Dowell RD, Leinwand LA (2015) Prolonged Cre expression driven by the \u03b1-myosin heavy chain promoter can be cardiotoxic. J Mol Cell Cardiol 86:54\u201361. https:\/\/doi.org\/10.1016\/j.yjmcc.2015.06.019","journal-title":"J Mol Cell Cardiol"},{"key":"7_CR24","doi-asserted-by":"publisher","unstructured":"Rehmani T, Salih M, Tuana BS (2019) Cardiac-specific Cre induces age-dependent dilated cardiomyopathy (DCM) in mice. Molecules 24(6). https:\/\/doi.org\/10.3390\/molecules24061189","DOI":"10.3390\/molecules24061189"},{"issue":"1","key":"7_CR25","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1172\/jci119509","volume":"100","author":"R Agah","year":"1997","unstructured":"Agah R, Frenkel PA, French BA, Michael LH, Overbeek PA, Schneider MD (1997) Gene recombination in postmitotic cells. Targeted expression of Cre recombinase provokes cardiac-restricted, site-specific rearrangement in adult ventricular muscle in vivo. J Clin Invest 100(1):169\u2013179. https:\/\/doi.org\/10.1172\/jci119509","journal-title":"J Clin Invest"},{"issue":"1","key":"7_CR26","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1161\/hh1301.092687","volume":"89","author":"DS Sohal","year":"2001","unstructured":"Sohal DS, Nghiem M, Crackower MA, Witt SA, Kimball TR, Tymitz KM et al (2001) Temporally regulated and tissue-specific gene manipulations in the adult and embryonic heart using a tamoxifen-inducible Cre protein. Circ Res 89(1):20\u201325. https:\/\/doi.org\/10.1161\/hh1301.092687","journal-title":"Circ Res"},{"issue":"2","key":"7_CR27","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/0167-4781(90)90039-5","volume":"1049","author":"RV Trask","year":"1990","unstructured":"Trask RV, Billadello JJ (1990) Tissue-specific distribution and developmental regulation of M and B creatine kinase mRNAs. Biochim Biophys Acta 1049(2):182\u2013188. https:\/\/doi.org\/10.1016\/0167-4781(90)90039-5","journal-title":"Biochim Biophys Acta"},{"issue":"21","key":"7_CR28","doi-asserted-by":"publisher","first-page":"9491","DOI":"10.1128\/MCB.25.21.9491-9502.2005","volume":"25","author":"J Luo","year":"2005","unstructured":"Luo J, McMullen JR, Sobkiw CL, Zhang L, Dorfman AL, Sherwood MC et al (2005) Class IA phosphoinositide 3-kinase regulates heart size and physiological cardiac hypertrophy. Mol Cell Biol 25(21):9491\u20139502","journal-title":"Mol Cell Biol"},{"issue":"1","key":"7_CR29","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.1038\/s41467-020-16345-y","volume":"11","author":"A Ferdous","year":"2020","unstructured":"Ferdous A, Wang ZV, Luo Y, Li DL, Luo X, Schiattarella GG et al (2020) FoxO1\u2013Dio2 signaling axis governs cardiomyocyte thyroid hormone metabolism and hypertrophic growth. Nat Commun 11(1):2551. https:\/\/doi.org\/10.1038\/s41467-020-16345-y","journal-title":"Nat Commun"},{"issue":"3","key":"7_CR30","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1172\/jci60329","volume":"122","author":"PK Battiprolu","year":"2012","unstructured":"Battiprolu PK, Hojayev B, Jiang N, Wang ZV, Luo X, Iglewski M et al (2012) Metabolic stress-induced activation of FoxO1 triggers diabetic cardiomyopathy in mice. J Clin Invest 122(3):1109\u20131118. https:\/\/doi.org\/10.1172\/jci60329","journal-title":"J Clin Invest"},{"issue":"9","key":"7_CR31","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1161\/CIRCULATIONAHA.120.046356","volume":"142","author":"J Pfleger","year":"2020","unstructured":"Pfleger J, Coleman Ryan C, Ibetti J, Roy R, Kyriazis Ioannis D, Gao E et al (2020) Genomic binding patterns of forkhead box protein O1 reveal its unique role in cardiac hypertrophy. Circulation 142(9):882\u2013898. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.120.046356","journal-title":"Circulation"}],"container-title":["Methods in Molecular Biology","FOXO Transcription Factors"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-4217-7_7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T16:08:14Z","timestamp":1732118894000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-4217-7_7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,21]]},"ISBN":["9781071642160","9781071642177"],"references-count":31,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-4217-7_7","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"type":"print","value":"1064-3745"},{"type":"electronic","value":"1940-6029"}],"subject":[],"published":{"date-parts":[[2024,11,21]]},"assertion":[{"value":"21 November 2024","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}